tirzepatide for the treatment of obstructive sleep apnea and obesity Clinical Impact on Patients With OSA PDF) Tirzepatide for the Treatment
Description
Broader health protection: Improvements in liver markers may reduce the risk of metabolic dysfunction and MASLD/MASH (fatty liver progression)
These include ketamine therapy IV (the most closely monitored and widely studied method), intranasal sprays, and oral lozenges
Science 388 , eadt0548 (2025)
As a result, dozens of upstream and downstream neural targets of 5-HT have been identified, revealing a multitude of neural circuits involved in mediating the anorexigenic effect of 5-HT
95 Rocca, A
